Evaluating the role of RAD52 and its interactors as novel potential molecular targets for hepatocellular carcinoma.
Li P, Xu Y, Zhang Q, Li Y, Jia W, Wang X, Xie Z, Liu J, Zhao D, Shao M, Chen S, Mo N, Jiang Z, Li L, Liu R, Huang W, Chang L, Chen S, Li H, Zuo W, Li J, Zhang R, Yang X.
Li P, et al. Among authors: xie z.
Cancer Cell Int. 2019 Nov 6;19:279. doi: 10.1186/s12935-019-0996-6. eCollection 2019.
Cancer Cell Int. 2019.
PMID: 31719794
Free PMC article.